Research guide · Copper peptides
What Is GHK-Cu? Complete Copper Tripeptide Research Guide for UK Laboratory Research
What is GHK-Cu? GHK-Cu (glycyl-histidyl-lysine copper) is a naturally occurring copper-bound tripeptide complex consisting of three amino acids (glycine, histidine, lysine) bound to a divalent copper ion.
It is a well-characterised copper peptide complex in the published literature, with in-vitro research covering fibroblast biology, copper-dependent enzyme research, collagen gene expression research, and antioxidant pathway research at the cellular level.
This guide sets out exactly what GHK-Cu is at the molecular level, how the copper binding mechanism works, and how UK laboratory researchers source GHK-Cu with full documentation transparency.
GHK-Cu is supplied for in vitro laboratory research only. It is not a licensed medicinal product under the UK Human Medicines Regulations 2012, and no dosing or administration guidelines are provided in this guide or in any Ascend Peptides UK documentation. The compound is supplied to qualified research professionals (laboratories, academic institutions, research scientists) for in-vitro cellular research applications across two principal research categories: skin biology research and tissue-model research. Ascend sends GHK-Cu samples to Janoshik for independent HPLC analysis; the published certificate currently covers one tested vial of the GHK-Cu 100mg format.
What Is GHK-Cu at the Molecular Level?
GHK-Cu is a copper-bound tripeptide complex with two structural components: a three-amino acid peptide chain (the GHK tripeptide) and a divalent copper ion (Cu2+) chelated to the peptide through specific binding residues. Together, the two components form a single coordinated complex with chemical and biological properties that differ from those of the unbound peptide or free copper ion alone.
The compound is supplied to laboratories as a lyophilised (freeze-dried) blue-tinted powder for reconstitution before in vitro research use. The molecular structure and key chemical properties of GHK-Cu are documented below.
|
Molecular Property |
Value |
|---|---|
|
Compound name |
GHK-Cu (Glycyl-Histidyl-Lysine Copper) |
|
Other names |
Copper tripeptide-1; prezatide copper |
|
Peptide class |
Copper-bound tripeptide complex |
|
Amino acid sequence |
Gly-His-Lys (glycine, histidine, lysine) |
|
Bound metal ion |
Cu2+ (divalent copper) |
|
Molecular formula |
C14H22CuN6O4 |
|
Molecular weight |
≈ 401.9 g/mol (free GHK peptide: 340.4 g/mol) |
|
CAS number |
89030-95-5 (copper complex); 49557-75-7 (free GHK) |
|
Identifiers |
UNII 6BJQ43T1I9; PubChem CID 10111685 |
|
Chelation residues |
Glycine N-terminal amine + Gly–His amide nitrogen + histidine imidazole nitrogen |
|
Visual appearance |
Blue to violet-tinted lyophilised powder (due to Cu2+ chromophore) |
|
Supplied format |
Lyophilised powder for reconstitution |
|
Storage |
See each product page (currently being verified with the manufacturer) |
The defining structural property of GHK-Cu is the copper binding geometry. The Cu2+ ion is coordinated by the N-terminal amine nitrogen of glycine, the deprotonated amide nitrogen between glycine and histidine, and the imidazole nitrogen of histidine.
This square-planar copper coordination distinguishes GHK-Cu from the unbound GHK peptide and is believed to contribute to its copper-dependent activity in research models. The blue to violet visual appearance of the lyophilised powder is a direct consequence of the Cu2+ d-orbital electron transitions, which absorb light in the orange to red region of the visible spectrum.
Janoshik’s GHK-Cu analysis is an HPLC method that reports measured content and purity for the vial tested. The published report covers one tested vial labelled GHK-Cu 100mg; its batch reference and results are listed with the report on the CoA page, and what it does and does not show is set out on the GHK-Cu 100mg page. The complete laboratory quality control workflow is documented on the how we test peptides page.
How Does the Copper Binding Mechanism Work?
The copper binding mechanism is the operational key to understanding GHK-Cu research applications. Unlike most research peptides that act through receptor-mediated signalling pathways, much of the discussion of GHK-Cu concerns copper. A leading hypothesis is that the GHK peptide acts as a copper carrier, although the peptide itself also shows activity in laboratory studies. The three points below summarise how the literature describes the copper binding.
Property 1: Copper Coordination Geometry
The Cu2+ ion in GHK-Cu is held in a square-planar coordination geometry mainly by three nitrogen donors from the peptide: the glycine N-terminal amine, the adjacent amide nitrogen and the histidine imidazole nitrogen.
Binding to GHK holds copper in a defined complex rather than as free copper ions, which matters when interpreting copper-dependent results in cell experiments (Hureau et al., 2011).
Property 2: Conditional Copper Release
It has been proposed that copper bound to GHK can be exchanged with other copper-binding molecules in cells, for example under changes in local conditions such as pH.
If this exchange occurs, it would let GHK-Cu supply copper to copper-dependent enzymes in a controlled way rather than as free copper ions. This remains a hypothesis rather than an established mechanism.
Property 3: Copper-Dependent Pathway Activation
Research interest has focused on copper-dependent enzymes that GHK-Cu could, in principle, supply with copper. These include copper-dependent superoxide dismutase research (relevant to antioxidant pathway research), lysyl oxidase research (relevant to extracellular matrix and collagen cross-linking research), and cytochrome c oxidase research (relevant to mitochondrial enzyme research). The peptide carrier itself also has documented research activity, particularly in fibroblast biology research.
Why GHK-Cu Sits in Two Research Categories
GHK-Cu is positioned across two distinct research categories within the Ascend Peptides UK catalogue. The compound is positioned in both the tissue-model research peptides category (for tissue research model applications) and the skin and cellular research peptides category (for skin biology research model applications).
The dual positioning reflects the actual published in-vitro research literature, which spans both application domains. Researchers select GHK-Cu based on the specific experimental focus of the research programme.
|
Research Category |
Primary Research Applications |
Cell Models |
|---|---|---|
|
Recovery research |
Tissue research models, tissue-model biology research, copper-dependent enzyme research |
General tissue cell line models, fibroblast research, copper-dependent enzyme assays |
|
Skin biology research |
Fibroblast biology, collagen gene expression, and dermal extracellular matrix research |
Dermal fibroblast cell lines, keratinocyte cell lines, and melanocyte research models |
For UK researchers working on tissue research models or combined multi-compound recovery research protocols, GHK-Cu appears alongside BPC-157 and TB-500 in the Tri Regenerative Complex bundle. For UK researchers working on skin biology models or melanocyte research, GHK-Cu appears alongside the melanocortin compounds MT1 and MT2 in the skin and cellular research peptides category. The same product pages and published documentation apply in both research contexts.
GHK-Cu Research Applications in UK Laboratory Research
UK laboratory researchers working with GHK-Cu typically apply the compound across four research application areas. The application chosen depends on the specific experimental focus of the research programme. The fibroblast and collagen work has the largest published literature base, which dates back to the isolation of the GHK tripeptide from human plasma in 1973 (Pickart and Thaler, 1973).
Application 1: Fibroblast Biology Research in Dermal Cell Line Models
Fibroblast biology research examines the cellular biology of connective tissue cells, including fibroblast migration, proliferation kinetics, and extracellular matrix production. GHK-Cu has been investigated in dermal fibroblast cell line models with documented research applications covering fibroblast migration assays, fibroblast proliferation kinetic studies, and collagen gene expression analysis at the cellular level. This is among the more commonly discussed GHK-Cu research categories in the in-vitro literature.
Application 2: Collagen Gene Expression Research
Collagen is the principal structural protein of the extracellular matrix in connective tissue, with multiple gene products (Type I, Type III, Type IV) studied in distinct research contexts. GHK-Cu has been investigated in collagen gene expression research at the cellular level. In fibroblast cultures, the copper complex was reported to stimulate collagen synthesis from picomolar concentrations, with a maximum near 1 nM (Maquart et al., FEBS Letters, 1988). This research application sits at the intersection of fibroblast biology research and copper-dependent enzyme research.
Application 3: Copper-Dependent Enzyme Research
Multiple cellular enzymes require copper as a catalytic cofactor, including superoxide dismutase 1 (SOD1, antioxidant pathway), lysyl oxidase (collagen cross-linking), and cytochrome c oxidase (mitochondrial electron transport). GHK-Cu has been proposed as a copper carrier for these enzymes, which links it to antioxidant and extracellular matrix research; this role is a hypothesis rather than an established mechanism. This research application connects GHK-Cu to broader research areas, including antioxidant biology and mitochondrial research at the cellular level.
Application 4: Tissue Recovery Research in Combined Multi-Compound Protocols
GHK-Cu is one of the three compounds in Ascend’s combined recovery research bundle, alongside BPC-157 (a 15-amino-acid peptide) and TB-500 (a fragment carrying the actin-binding motif of thymosin beta-4). The three compounds are studied in different mechanistic contexts, but published studies of them in combination are few, so a combined design does not by itself establish additive or independent effects. For combined recovery research programmes, the Tri Regenerative Complex bundle is available at £85 per bundle, with all three compounds from a single supplier.
Evidence status: what is and is not established
Most published GHK-Cu research comes from cell culture and animal models. The collagen findings above come from fibroblast cultures, and the wound-healing work reviewed by Pickart and colleagues comes from animal models (rats, mice, rabbits, pigs and dogs). Human data are limited to small studies of topically applied cosmetic creams, reported only briefly in a narrative review by authors working on GHK products; they do not establish any medical effect and do not relate to research material supplied by Ascend (Pickart et al., 2015). The proposed copper-carrier role, how the gene-expression findings translate into biological effects, and how in-vitro concentrations relate to levels in tissue all remain open questions (Pickart and Margolina, 2018).
GHK-Cu UK Supplier Standards: What to Verify Before Purchase
GHK-Cu is a particularly important compound to source from a verified UK supplier because of the copper-binding component. The biological activity of GHK-Cu in research models depends on the integrity of the copper-peptide coordination complex.
Substandard manufacturing can produce material where the copper is not properly bound to the peptide, or where the peptide is present without the required copper content, both of which would invalidate downstream research results. Four documentation standards distinguish a verified UK supplier of GHK-Cu from an unverified one. The complete framework is set out on the batch verification page.
|
Documentation Standard |
What to Look For |
Ascend Peptides UK |
|---|---|---|
|
HPLC purity verification |
A named independent laboratory and a stated purity figure |
Independent HPLC by Janoshik (GHK-Cu 100mg certificate published) |
|
LC-MS molecular identity |
A mass-spectrometry identity result |
No LC-MS report published yet; the 100mg Janoshik report gives HPLC content and purity |
|
Batch-specific Certificate of Analysis |
A certificate naming the batch tested |
Batch-numbered certificate for GHK-Cu 100mg (one tested vial; the batch is named on the certificate) |
|
UK dispatch standards |
A stated dispatch cut-off |
Same working-day UK dispatch on in-stock orders before 3pm (Mon–Fri) |
The published Janoshik certificate for GHK-Cu 100mg reports purity and measured content for one tested vial. Its measured content is below the 100mg nominal strength on the label, so it does not show that every vial contains 100mg. Purity is a chromatographic measure and does not by itself establish quantity; the measurement basis and how the tested batch relates to current stock are still being confirmed. The Janoshik Certificate of Analysis is publicly accessible from the CoA archive before the order is placed. For the complete research grade standards framework, see the research grade standards page.
Storing and Handling GHK-Cu
This article does not set a storage temperature for GHK-Cu. Storage requirements are currently being verified with the manufacturer, and the current position is given on each product page: see GHK-Cu 50mg and GHK-Cu 100mg. General handling information is in the peptide storage guide.
Preparation and laboratory procedures remain the responsibility of the researcher.
Handling points specific to copper peptides
-
The Cu2+ complex absorbs visible light, which gives the material its blue to violet colour, so protect it from prolonged light exposure.
-
Keep the vial sealed until it is needed and record the batch number shown on the label against your experiment.
-
Solvent choice, aliquoting and how long a prepared solution is used are decisions for your own validated laboratory protocol; Ascend does not publish an in-use period.
-
For laboratory research use only; not for human or veterinary use.
-
Current certificates of analysis are listed on the CoA page.
GHK-Cu in the Tri Regenerative Complex Bundle
For UK research programmes running combined recovery research protocols, GHK-Cu is the third compound, alongside BPC-157 and TB-500, in Ascend’s multi-compound recovery research bundle.
The three compounds are discussed in different mechanistic contexts: BPC-157 in angiogenic and fibroblast signalling research, TB-500 as a fragment carrying thymosin beta-4’s actin-binding motif, and GHK-Cu in copper-dependent pathway research. Published studies of the three in combination are few, so a combined design does not by itself establish additive or independent effects. The Tri Regenerative Complex bundle from Ascend Peptides UK pairs all three compounds at £85 per bundle, sourced from a single supplier.
|
Compound |
Mechanism |
Primary Pathway |
|---|---|---|
|
BPC-157 |
Pentadecapeptide signalling |
Angiogenic factor expression, fibroblast biology |
|
TB-500 |
Fragment of thymosin beta-4 carrying its actin-binding motif |
G-actin binding, cytoskeletal dynamics |
|
GHK-Cu |
Copper binding; proposed copper-carrier role |
Copper-dependent enzyme research, fibroblast research |
Why UK Researchers Source GHK-Cu from Ascend Peptides UK
- Independent HPLC testing by Janoshik; the published GHK-Cu certificate covers one tested vial of the 100mg format.
- Certificates are published on the CoA page so they can be checked before ordering.
- Each published certificate carries the batch number of the vial tested.
- Same working-day UK dispatch on in-stock orders before 3pm (Mon–Fri) via Royal Mail Tracked 24.
- Free UK delivery on orders of £50 or more.
- Tri Regenerative Complex bundle (BPC-157 + TB-500 + GHK-Cu) available at £85 for combined recovery research protocols.
- Dual category positioning across both skin biology and recovery research, with single-supplier sourcing across all compounds in either category. Single-supplier sourcing does not establish that supplied vials share a verified manufacturing lot.
What Is GHK-Cu? Frequently Asked Questions
What does GHK-Cu stand for?
GHK-Cu stands for Glycyl-Histidyl-Lysine Copper. GHK is the three-letter code for the tripeptide composed of glycine (G), histidine (H), and lysine (K). Cu is the chemical symbol for copper. The compound is a tripeptide bound to a divalent copper ion (Cu2+) in a square-planar coordination complex.
What is the molecular structure of GHK-Cu?
GHK-Cu is a copper-bound tripeptide complex with the molecular formula C14H22CuN6O4 and molecular weight approximately 401.9 g/mol. The peptide component is the three-amino acid sequence Gly-His-Lys. The Cu2+ ion is coordinated by the glycine N-terminal amine, the adjacent amide nitrogen and the histidine imidazole nitrogen. Ascend’s published Janoshik certificate for GHK-Cu 100mg reports measured content and purity for one tested vial; it does not confirm the sequence by mass spectrometry.
What is GHK-Cu used for in research?
In published in-vitro research literature, GHK-Cu has been studied across four principal application areas: fibroblast biology research in dermal cell line models, collagen gene expression research, copper-dependent enzyme research (SOD1, lysyl oxidase, cytochrome c oxidase), and tissue-model research in combined multi-compound laboratory protocols. All research applications are conducted in in-vitro cellular research models, not in human or veterinary clinical applications.
How does GHK-Cu differ from other research peptides?
Most research peptides act through protein-protein interactions, typically as ligands for cell surface receptors. Much of the research interest in GHK-Cu concerns copper-dependent pathways; a copper-carrier role for the GHK peptide has been proposed but is not established, and the peptide itself also shows activity in laboratory studies. This sets its research context apart from most receptor-targeting peptides, but it does not by itself establish independent or additive effects when GHK-Cu is combined with compounds such as BPC-157 or TB-500.
Why is GHK-Cu in both the skin and recovery research categories?
GHK-Cu has substantial published in-vitro research literature spanning both skin biology research models (fibroblast research, collagen gene expression, dermal extracellular matrix) and tissue research models (regenerative biology, copper-dependent enzyme pathways). Researchers select GHK-Cu based on the experimental focus of the specific research programme. The same product pages and published documentation apply in both research contexts. See the skin and cellular research peptides page or the recovery research peptides page for the relevant category framework.
What is the MHRA status of GHK-Cu in the UK?
GHK-Cu is not licensed as a medicinal product under the UK Human Medicines Regulations 2012. It is supplied strictly for in vitro laboratory research. The Medicines and Healthcare products Regulatory Agency (MHRA) is the relevant medicines regulator in the UK post Brexit (replacing the previous European Medicines Agency route).
How should GHK-Cu be stored?
Storage information is on the GHK-Cu 50mg and GHK-Cu 100mg product pages; storage requirements are currently being verified with the manufacturer. As a copper(II) complex, GHK-Cu should be protected from prolonged light exposure. General handling information is in the peptide storage guide.
How much does GHK-Cu cost from Ascend Peptides UK?
GHK-Cu is supplied by Ascend Peptides UK in 50mg and 100mg vials; current prices are shown on the GHK-Cu 50mg and GHK-Cu 100mg product pages. For combined research protocols, the Tri Regenerative Complex bundle (BPC-157 + TB-500 + GHK-Cu) is available at £85, with all three compounds sourced from a single supplier.
Order GHK-Cu from Ascend Peptides UK: Same Working-Day Dispatch on In-Stock Orders
Browse the GHK-Cu product pages for specifications, published documentation and same working-day UK dispatch on in-stock orders placed before 3pm, Monday to Friday. For combined laboratory research designs, the Tri Regenerative Complex bundle (BPC-157 + TB-500 + GHK-Cu, £85) is available at a reduced bundle price. For the recovery research category framework, see the recovery research peptides UK page. For the skin biology research category framework, see the skin and cellular research peptides UK page. Or start with the main research peptides UK hub for the complete supplier model.
Scientific references
- Hureau C, et al. (2011). X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties. Chem Eur J. 17(36):10151-60.
- Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-6.
- Pickart L, Vasquez-Soltero JM, Margolina A. (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015:648108.
- Pickart L, Thaler MM. (1973). Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 243(124):85-7.
- Pickart L, Margolina A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 19(7):1987.
RESEARCH USE ONLY
All products supplied by Ascend Peptides UK are intended strictly for in-vitro laboratory research purposes only. GHK-Cu is not a licensed medicinal product under the UK Human Medicines Regulations 2012 and is not for human or veterinary use. No dosing or administration guidelines are provided. Products are supplied to qualified research professionals only.